		<rss version="2.0">
		<channel>
		<title>Abilify News RSS Feed - Lawyer Seek Litigation</title>
		<link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Abilify-P9/News/</link>
		<description>What is Abilify?
Aripiprazole, marketed and sold under the name Abilify by Bristol Myers Squibb, is a medication that falls into the category of second-generation or atypical antipsychotics. In addition to Abilify, other medications that fall under the atypical antipsychotic category include Risperdal, Zyprexa, and Seroquel. Atypical antipsychotics are prescribed for the treatment of symptoms associated with schizophrenia and bipolar I disorder. Symptoms of schizophrenia that Abilify is used to treat may include hearing voices or seeing things that are not there, while bipolar I symptoms for which Abilify is prescribed include the manic episodes associated with this mood disorder. ... </description>
		<language>en-us</language>
		
					<item>
			<title>Accident Raises Safety Concerns About Chinese Tires</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Abilify-P9/News/</link><description>Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature.</description>			
			</item>			
					<item>
			<title>Accident Raises Safety Concerns About Chinese Tires</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Abilify-P9/News/</link><description>Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature</description>			
			</item>			
				
		</channel>
		</rss> 
		